|1.||Yano, Tomohiro: 14 articles (01/2013 - 01/2003)|
|2.||Yamasaki, Hiroshi: 10 articles (06/2008 - 01/2003)|
|3.||Sato, Hiromi: 8 articles (06/2008 - 02/2005)|
|4.||Ueno, Koichi: 7 articles (06/2008 - 07/2004)|
|5.||Hagiwara, Hiromi: 7 articles (06/2008 - 02/2005)|
|6.||Hagiwara, Kiyokazu: 7 articles (05/2006 - 05/2003)|
|7.||Negishi, Etsuko: 6 articles (03/2007 - 07/2004)|
|8.||Fukumoto, Keiko: 5 articles (06/2008 - 02/2005)|
|9.||Fujimoto, Eriko: 5 articles (10/2006 - 07/2004)|
|10.||Virgona, Nantiga: 4 articles (01/2013 - 05/2006)|
|1.||Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
10/01/2002 - "To report a Chinese Charcot-Marie-Tooth disease (CMT) family whose proband had abnormal brainstem auditory evoked potentials (BAEPs) and to study its relationship with connexin 32 (Cx32) gene mutation. "
02/01/2001 - "The aim of the present study was to identify the mutations in the connexin 32 gene in French-Canadian families with X-linked Charcot-Marie-Tooth disease (CMTX). "
04/01/1998 - "X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study."
06/15/2014 - "Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease. "
06/01/2013 - "X-linked Charcot-Marie-Tooth disease (CMT Type X1, OMIM: 302800) represents a frequent cause of hereditary peripheral motor and sensory neuropathies and is associated with mutations in GJB1 encoding the gap junction beta 1 protein connexin 32 (Cx32). "
02/01/2002 - "Frozen sections of 23 normal, 43 BPH and 40 cancer involved prostates were evaluated for the presence, staining intensity and pattern of connexin 32 and 43 by immunocytochemical testing. "
12/01/2001 - "Frozen sections of 23 normal, 43 BPH and 40 cancer involved prostates were evaluated for the presence, staining intensity and pattern of connexin 32 and 43 by immunocytochemical testing. "
01/02/1994 - "Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32."
01/01/1990 - "Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation."
01/01/2010 - "Connexin expression by human granulosa cell tumors: Identification of connexin 32 as a tumor signature."
11/01/1995 - "No malignant cells from patients with carcinoma contained detectable connexin 32. "
01/01/1990 - "Morphometrical analysis also showed that in most of the carcinomas the number of gap junction spots stained with connexin 32 antibody was not less than that in the surrounding livers. "
01/01/1990 - "No decrease in connexin 32 mRNA expression was found in carcinomas compared with the surrounding nontumorous tissue. "
04/01/2008 - "5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene."
08/01/1996 - "This study was conducted to examine the possible relationship among connexin 32 (Cx32) expression, cell proliferation and differentiation in the normal stomach, N-methyl-N'-nitro-nitrosoguanidine (MNNG)-induced atrophic gastritis, and carcinoma in rats. "
|4.||Neoplasm Metastasis (Metastasis)
01/01/2007 - "Consequently, the aim of the present study was the evaluation of the expression of connexin 32 (Cx32) in primary breast tumors (PTs) and matched-paired metastases to lymph nodes (MLNs) in correlation with selected clinicopathological features. "
02/01/2009 - "Correlations of connexin 32 and 26 expressions to smoking, tumor size, histological type, the degree of differentiation, lymph node metastasis and prognosis were analyzed. "
06/01/2008 - "The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma."
03/01/2007 - "Regulation of renal cell carcinoma cell proliferation, invasion and metastasis by connexin 32 gene."
01/01/2007 - "Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer."
05/01/1999 - "Previous studies showed that the expression of connexin 32 (Cx32), the polypeptide subunit component of the major hepatic gap junction, is reduced in liver by changes in mRNA stability during bacterial lipopolysaccharide (LPS)-induced inflammation. "
06/01/2015 - "We investigated connexin 32 (Cx32)-deficient mice, a model for the X-linked form of Charcot-Marie-Tooth neuropathy (CMT1X), regarding the impact of low-grade inflammation on Schwann cell phenotype. "
02/01/1996 - "Posttranscriptional regulation of connexin 32 expression in liver during acute inflammation."
02/01/2012 - "We demonstrate that connexin 32 (Cx32), a key hepatic gap junction protein, is an essential mediator of DILI by showing that mice deficient in Cx32 are protected against liver damage, acute inflammation and death caused by liver-toxic drugs. "
|1.||Connexin 43 (Connexin43)
|2.||Proteins (Proteins, Gene)
|3.||Complementary DNA (cDNA)
|4.||Messenger RNA (mRNA)
|6.||2-Acetylaminofluorene (2 Acetylaminofluorene)
|10.||Myelin P0 Protein (Myelin Protein Zero)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Renal Dialysis (Hemodialysis)